Insect Cell Lines Market Share

  • Report ID: 5339
  • Published Date: Oct 20, 2023
  • Report Format: PDF, PPT

Insect Cell Lines Market Share

North American Market Forecast

The insect cell lines market in North America is predicted to account for the largest share of 35% by 2036 impelled by increasing spending in the production of vaccines. This, as a result, may lead to increasing development of vaccines in the region which is expected to drive the demand for insect cell lines. For instance, as of 2020, American biopharmaceutical companies worked on over 250 vaccines to prevent and treat diseases including cancer, and other autoimmune disorders.

The US government spent over USD 31 billion on the research, development, and acquisition of mRNA COVID-19 vaccines, with significant sums spent in the three decades before the pandemic and through March 2022.

European Market Statistics

The Europe insect cell lines market is estimated to be the second largest, during the forecast period led by rising spending in research & development in the healthcare industry. This has led to an increase in focus on research and development in the area of creative medicines by the pharmaceutical industry in the region which is essential if diseases and disorders are to be treated efficiently. In Europe, the research-based pharmaceutical business alone spent around €37 billion on R&D in 2019 and over €35 billion in 2020.

Research Nester
Insect Cell Lines Market Region
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar

  • Report ID: 5339
  • Published Date: Oct 20, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing production of vaccines and the rising need for insect-derived products are the major factors driving the growth of the market.

The market size of insect cell lines is anticipated to attain a CAGR of 12% over the forecast period, i.e., 2024 - 2036.

The major players in the market are Sigma-Aldrich Corporation, GE Healthcare Technologies Inc., Lonza Group, Becton, Dickinson & Company, HiMedia Laboratories LLC, Takara Bio Inc., CellGenix GmbH, Atlanta Biologicals Inc., PromoCell GmbH.

The high five segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying